Seasonal Patterns in Tetracycline-Associated Hyperpigmentation Among Patients With Acne Vulgaris

November 2023 | Volume 22 | Issue 11 | e9 | Copyright © November 2023


Published online October 20, 2023

doi:10.36849/JDD.7409e

Katherine Young BS MEnga, Angel D. Pagan BSb,c, Jaewon Yoon BAa, Ethiopia Getachew BSa, Bonnie Leung BScc, Nga Nguyen BAc, Yevgeniy R. Semenov MD MAc, Arash Mostaghimi MD MPA MPHd*, Nicholas Theodosakis MD PhDc*

aHarvard Medical School, Boston, MA 
bPonce Health Sciences University School of Medicine, Ponce, Puerto Rico 
cMassachusetts General Hospital, Department of Dermatology, Boston, MA 
dBrigham and Women’s Hospital, Department of Dermatology, Boston, MA

*Denotes equal contribution

Abstract
Background: Oral tetracyclines (TCNs) are commonly prescribed for acne, but they have been shown to increase the risk of hyperpigmentation, particularly in the setting of sun exposure.
Objective: We evaluated seasonal trends in TCN-associated hyperpigmentation incidence in addition to Google search trends for hyperpigmentation-related terms.
Methods: We performed a retrospective review of acne patients seen at Massachusetts General Brigham and Women’s Hospital between 1992 and 2022. We calculated the incidence of new hyperpigmentation diagnoses for each drug cohort. We also analyzed search volume of hyperpigmentation-related terms extracted from Google Trends.
Results: Seasonal differences in new hyperpigmentation diagnoses were identified among acne patients prescribed doxycycline (P=0.016), with peak incidence in April. In the control group of patients who had never received a TCN, diagnoses peaked in May. There were no significant seasonal differences among patients prescribed minocycline (P=0.885). There was greater search volume for hyperpigmentation-related terms in spring and summer compared to fall and winter (P<0.001). Limitations of this study include its retrospective nature and reliance on prescription and diagnosis coding data.
Conclusions: Our findings support the seasonal periodicity of acne-related hyperpigmentation, underscoring the importance of photoprotection counseling for patients with acne. Additionally, doxycycline may be associated with an earlier onset of hyperpigmentation, suggesting a potential benefit of considering minocycline or other alternatives to doxycycline.

J Drugs Dermatol. 2023;22(11):e9-e11    doi:10.36849/JDD.7409e

INTRODUCTION

Post-inflammatory hyperpigmentation is a common sequela of acne.1 Although oral tetracyclines (TCNs) are widely prescribed for acne given their anti-inflammatory properties, they independently increase the risk of hyperpigmentation, particularly in the setting of sun exposure.2 Nevertheless, the interaction between TCN-associated hyperpigmentation and seasonal variation in sun exposure in the setting of acne has not been rigorously explored. Here, we examine seasonality in hyperpigmentation incidence in addition to Google search trends.

We queried the Massachusetts General Brigham and Women’s Hospital registry (1992-2022) for acne patients using a validated algorithm (n=50,471).3,4 Patients who had ever received an International Classification of Diseases (ICD) code for melasma (L81.1, n=978) or who had received an ICD code for hyperpigmentation (709.00, 709.09, L81.0, L81.4, L81.8, L81.9) prior to their first acne diagnosis were excluded (n=4,315). Patients who had ever received isotretinoin were also excluded, given the higher disease severity and differential drug effects in this population (n=6,537). We identified cohorts who were prescribed doxycycline (n=546) or minocycline (n=148) monotherapy within one year of acne diagnosis and calculated the incidence of new-onset hyperpigmentation at least two weeks after the first TCN prescription, comparing against a cohort of acne patients who were never prescribed a TCN (n=2,136).5 Google Trends is a tool that provides real-time data about Google search frequencies from 2004 onwards. Relative search volume for a given term is represented by the search volume index (SVI), which ranges from 0 to 100.6 We extracted and combined SVI data for the terms "hyperpigmentation" and